Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARES-Pilot: Caffeine Therapy in Preterm Infants
NCT07456670Phase 2Not yet recruiting
- Sponsor
- Queen's University
- Start
- Apr 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in preterm birth comparing Caffeine Citrate Group with Placebo Group (2 arms). Primary endpoints: Recruitment/Eligibility Proportion up to 24 months, Treatment Adherence Proportion and 1 more. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
caffeine
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT07456670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456670.